What is Glioblastoma (GBM, Symptoms and Treatment
-
What Is Glioblastoma?
-
How Is Glioblastoma Diagnosed?
-
Future Directions and Research in Glioblastoma Treatment
-
Frequently Asked Questions
Among brain tumors, some types progress rapidly, exhibit complex structures, and follow an aggressive course, significantly impacting both the patient and the treatment process. One of these tumors, known as one of the most common and challenging forms of brain cancer, requires immediate treatment upon diagnosis.
This fast-spreading tumor type not only affects the region where it originates but can also invade surrounding healthy brain tissue. Therefore, diagnosis, treatment, and follow-up require an extremely sensitive and multidisciplinary approach.
What Is Glioblastoma?
Glioblastoma, also known as glioblastoma multiforme (GBM), is a type of tumor that originates from glial cells in the central nervous system, typically developing in the cerebral hemispheres. It is classified as a grade 4 malignant glial tumor in medical literature and is most commonly diagnosed in middle-aged and older adults.
Glioblastoma is not just defined pathologically; its behavior, growth rate, and response to treatment make it unique among brain tumors. GBM has the ability to cross the blood-brain barrier, stimulate blood vessel formation, and infiltrate surrounding brain tissue.
Common Symptoms of Glioblastoma
Glioblastoma symptoms vary depending on the tumor’s location in the brain. However, the most frequent symptoms include:
- Persistent headaches, often more severe in the morning and worsening over time
- Nausea and vomiting due to increased intracranial pressure
- Seizures in individuals with no previous history of epilepsy
- Speech difficulties and trouble finding words when the tumor affects language areas
- Blurred vision, double vision, or visual field loss if visual pathways are involved
- Balance issues, walking difficulties, and coordination problems if located in motor-related areas
- Personality changes, decision-making challenges, cognitive slowdown, or memory issues, particularly with tumors in the frontal lobe
Causes and Risk Factors of Glioblastoma
The exact cause of glioblastoma remains unknown, but several environmental and genetic factors may contribute to its development:
- Age: The risk increases significantly in individuals over the age of 50
- Gender: Men are more likely to develop GBM than women
- Radiation Exposure: Prior exposure to ionizing radiation may increase risk
- Genetic Mutations: Abnormalities in genes such as TP53, EGFR, and IDH are linked to GBM development
- Immunosuppression: Higher incidence in immunocompromised individuals (e.g., transplant recipients, HIV/AIDS patients)
- Cell Phones and EMFs: While claims exist, no definitive scientific link has been proven
How Is Glioblastoma Diagnosed?
Diagnosing glioblastoma involves a comprehensive, multidisciplinary approach:
- Clinical Evaluation: Neurological examination to determine symptom-related brain regions
- Imaging: MRI with contrast to assess tumor location, size, surrounding edema, and spread
- Biopsy: Tissue sampling through minimally invasive surgery to confirm diagnosis
- Pathology: Microscopic examination to analyze cell structure and genetic profile (IDH mutation, MGMT methylation)
- Classification: WHO classifies it as Grade 4 glioblastoma, the highest malignancy level
Glioblastoma Treatment Options
Treatment of GBM must be tailored individually by a multidisciplinary team, as surgery alone is often insufficient. The standard treatment plan typically includes:
- Surgical Resection: Removal of as much tumor tissue as possible using microsurgical techniques
- Radiotherapy: Targeted radiation to eliminate remaining microscopic tumor cells
- Chemotherapy: Temozolomide (TMZ) is the most commonly used oral chemotherapeutic agent, often combined with radiation
- Immunotherapy: Emerging therapies aim to harness the immune system to attack tumor cells
Treatment decisions consider genetic markers (MGMT, IDH), patient age, and general health
Prognosis and Life Expectancy in Glioblastoma
Glioblastoma has a generally poor prognosis due to its aggressive nature. However, timely and well-managed treatment can extend survival:
- Average Survival Time: Typically ranges from 12 to 18 months after diagnosis
- Improved Outcomes: Patients with MGMT methylation and IDH mutation may survive up to 2 years or longer
- Better Response in Younger Patients: Younger and healthier individuals tend to respond more favorably to treatment
Glioblastoma Recurrence
Glioblastoma has a high recurrence rate, even after complete treatment:
- Recurrence Timeline: Most commonly recurs within 6–9 months after initial treatment
- Second-line Options: May include repeat surgery, re-irradiation, alternative chemotherapy protocols, or clinical trial participation
- Close Monitoring: Due to high relapse rates, regular follow-up is critical
Future Directions and Research in Glioblastoma Treatment
Research in glioblastoma treatment is evolving rapidly, with promising advances including:
- Targeted Molecular Therapies: Drugs tailored to specific mutations in tumor cells
- Gene Therapy: Approaches to alter the tumor’s genetic composition
- Vaccine-Based Immunotherapies: Experimental treatments using the patient’s immune system to attack tumor cells
- Next-Generation Radiotherapy: Improved precision in targeting tumor tissue while sparing healthy brain areas
Though these treatments are not yet standard, they represent a hopeful outlook for future management.
Frequently Asked Questions
Is glioblastoma hereditary?
Most cases of GBM are sporadic, but hereditary syndromes like Li-Fraumeni or Turcot can increase the risk. Individuals with family history may benefit from genetic screening.
Can glioblastoma be cured?
Current therapies aim to control tumor growth and extend life rather than provide a full cure. However, ongoing research offers hope for more effective treatments in the future.
What are the side effects of glioblastoma treatment?
Common side effects include neurological deficits after surgery, fatigue from radiotherapy, and nausea or infection risk during chemotherapy. These can be managed with supportive care and medication.
Are there dietary recommendations for GBM patients?
A balanced diet rich in protein and fiber is advised. Some studies suggest the ketogenic diet may help, but it should be followed under expert supervision.
* Contents of this page is for informational purposes only. Please consult your doctor for diagnosis and treatment. The content of this page does not include information on medicinal health care at Liv Hospital .
